RGS RGS Healthcare Solutions

Tender glossary

Centralised procedure

Definition

The EU route in which the European Medicines Agency assesses a medicine and the European Commission grants one authorisation valid in every member state.

In practice

It is mandatory for many biologics and innovative medicines and optional for some generics.

Example

A biosimilar receives one EU-wide authorisation, valid in every member state at once. Launches and first tenders then follow country by country, often over several years.

Why it matters for suppliers

For tender planning, a central authorisation is only the start. Each country then decides on pricing and reimbursement, and buyers launch their own tenders on their own calendars, so competition from a newly authorised product arrives market by market.

Back to the glossary

See how this plays out in your own tenders

RGS tracks tenders and awards across Europe and applies these rules automatically.